Back بريستول-مايرز سكويب Arabic بريستول-مايرز سكويب ARZ بریستول-مایرز اسکوئیب AZB Bristol Myers Squibb Danish Bristol-Myers Squibb German Bristol Myers Squibb English Bristol Myers Squibb Esperanto Bristol-Myers Squibb Spanish بریستول-مایرز اسکوئیب Persian Bristol-Myers Squibb Finnish
.svg){kind=logo} | |
 Sebuah fasilitas riset dan pengembangan milik Bristol Myers Squibb di Lawrence, New Jersey | |
| Publik | |
| Kode emiten | NYSE: BMY Komponen S&P 100 Komponen S&P 500 |
| Industri | Farmasi |
| Didirikan | 1887 |
| Pendiri | William McLaren Bristol John Ripley Myers E. R. Squibb |
| Kantor pusat | 430 East 29th Street New York City, New York, Amerika Serikat |
Tokoh kunci | Giovanni Caforio, M.D. (Chairman & CEO) Charles Bancroft (CFO) |
| Pendapatan |  US$42,518 milyar (2020)[1] |
| US$30,745 milyar (2020)[1] | |
| ▲ US$8,995 milyar (2020)[1] | |
| Total aset | US$129,44 milyar (2019)[2] |
| Total ekuitas | US$59,70 milyar (2019)[2] |
Karyawan | 30.000 (2019)[2] |
| Situs web | BMS.com |
Bristol Myers Squibb (BMS) adalah sebuah perusahaan farmasi yang berkantor pusat di New York City.[3]
Bristol Myers Squibb memproduksi obat resep untuk sejumlah area terapeutik, seperti kanker, HIV/AIDS, penyakit kardiovaskular, diabetes, hepatitis, rheumatoid arthritis, dan gangguan jiwa.
Fasilitas riset dan pengembangan utama BMS terletak di Lawrence, New Jersey (sebelumnya milik Squibb, di dekat Princeton), New Brunswick, New Jersey, dan Redwood City, California; dengan fasilitas lain di Devens dan Cambridge, Massachusetts, East Syracuse, New York, Braine-l'Alleud, Belgia, Tokyo, Jepang, Bangalore, India, dan Wirral, Britania Raya.[4][5] BMS juga pernah memiliki fasilitas riset dan pengembangan di Wallingford, Connecticut (sebelumnya milik Bristol-Myers).[6]
- ^ a b c "Bristol Myers Squibb 2020 Full-Year Financial Results" (PDF). s21.q4cdn.com. Bristol Myers Squibb. 5 February 2021.
- ^ a b c "Bristol Myers Squibb 2019 Annual Report" (PDF). s21.q4cdn.com. Bristol Myers Squibb. 23 February 2020.
- ^ "Bristol-Myers Squibb - Contact Us". March 18, 2020.
- ^ "Bristol-Myers Squibb and Biocon's Syngene open new R&D Facility at Biocon Park" (Siaran pers). Diarsipkan dari versi asli tanggal 29 September 2012. Diakses tanggal 16 May 2012.
- ^ https://www.bms.com/about-us/our-company/worldwide-facilities/our-research-facilities.html
- ^ "Bristol-Myers Squibb to lay off 149 as Wallingford, Connecticut, site nears closure". Fiercepharma.com. Diakses tanggal 3 February 2019.